登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRxiv，5月3日，Enhanced Contact Investigations for Nine Early Travel-Related Cases of SARS-CoV-2 in the United States》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-05-04

  • Enhanced Contact Investigations for Nine Early Travel-Related Cases of SARS-CoV-2 in the United States

    View ORCID ProfileRachel M Burke, Sharon Balter, Emily Barnes, Vaughn Barry, Karri Bartlett, Karlyn D Beer, Isaac Benowitz, Holly M Biggs, Hollianne Bruce, Jonathan Bryant-Genevier, Jordan Cates, Kevin Chatham-Stephens, Nora Chea, Howard Chiou, Demian Christiansen, Victoria Chu, Shauna Clark, Sara H. Cody, Max Cohen, Erin E Conners, Vishal Dasari, Patrick Dawson, Traci DeSalvo, Matthew Donahue, Alissa Dratch, Lindsey Duca, Jeffrey Duchin, Jonathan W Dyal, Leora R Feldstein, Marty Fenstersheib, Marc Fischer, Rebecca Fisher, Chelsea Foo, Brandi Freeman-Ponder, Alicia M Fry, Jessica Gant, Romesh Gautom, Isaac Ghinai, Prabhu Gounder, Cheri T Grigg, Jeffrey Gunzenhauser, Aron J Hall, George S Han, Thomas Haupt, Michelle Holshue, Jennifer Hunter, Mireille B Ibrahim, Max W Jacobs, M. Claire Jarashow, Kiran Joshi, Talar Kamali, Vance Kawakami, Moon Kim, Hannah Kirking, Amanda Kita-Yarbro, Rachel Klos, Miwako Kobayashi, Anna Kocharian, Misty Lang, Jennifer Layden, Eva Leidman, Scott Lindquist, Stephen Lindstrom, Ruth Link-Gelles, Mariel Marlow, Claire P Mattison, Nancy McClung, Tristan McPherson, Lynn Mello, Claire M Midgley, Shannon Novosad, Megan T Patel, Kristen Pettrone, Satish K Pillai, Ian W Pray, Heather E Reese, Heather Rhodes, Susan Robinson, Melissa Rolfes, Janell Routh, Rachel Rubin, Sarah L Rudman, Denny Russell, Sarah Scott, Varun Shetty, Sarah E Smith-Jeffcoat, Elizabeth A Soda, Chris Spitters, Bryan Stierman, Rebecca Sunenshine, Dawn Terashita, Elizabeth Traub, Grace E Vahey, Jennifer R Verani, Megan Wallace, Matthew Westercamp, Jonathan Wortham, Amy Xie, Anna Yousaf, Matthew Zahn

    doi: https://doi.org/10.1101/2020.04.27.20081901

    Abstract

    Background Coronavirus disease 2019 (COVID-19), the respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has since become pandemic. As part of initial response activities in the United States, enhanced contact investigations were conducted to enable early identification and isolation of additional cases and to learn more about risk factors for transmission. Methods Close contacts of nine early travel-related cases in the United States were identified. Close contacts meeting criteria for active monitoring were followed, and selected individuals were targeted for collection of additional exposure details and respiratory samples. Respiratory samples were tested for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction (RT-PCR) at the Centers for Disease Control and Prevention. Results There were 404 close contacts who underwent active monitoring in the response jurisdictions; 338 had at least basic exposure data, of whom 159 had at least 1 set of respiratory samples collected and tested. Across all known close contacts under monitoring, two additional cases were identified; both secondary cases were in spouses of travel-associated case patients. The secondary attack rate among household members, all of whom had at least 1 respiratory sample tested, was 13% (95% CI: 4 - 38%). Conclusions The enhanced contact tracing investigations undertaken around nine early travel-related cases of COVID-19 in the United States identified two cases of secondary transmission, both spouses. Rapid detection and isolation of the travel-associated case patients, enabled by public awareness of COVID-19 among travelers from China, may have mitigated transmission risk among close contacts of these cases.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.04.27.20081901v1
22浏览量
原文链接
相关报告

  • 《MedRxiv，4月3日，Using ILI surveillance to estimate state-specific case detection rates and forecast SARS-CoV-2 spread in the United States》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-04-05
    • Using ILI surveillance to estimate state-specific case detection rates and forecast SARS-CoV-2 spread in the United States View ORCID ProfileJustin D Silverman, View ORCID ProfileAlex D Washburne doi: https://doi.org/10.1101/2020.04.01.20050542 This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice. Abstract Detection of SARS-CoV-2 infections to date has relied on RT-PCR testing. However, a failure to identify early cases imported to a country, bottlenecks in RT-PCR testing, and the existence of infections which are asymptomatic, sub-clinical, or with an alternative presentation than the standard cough and fever have resulted in an under-counting of the true prevalence of SARS-CoV-2. Here, we show how publicly available CDC influenza-like illness (ILI) outpatient surveillance data can be repurposed to estimate the detection rate of symptomatic SARS-CoV-2 infections. We find a surge of non-influenza ILI above the seasonal average and show that this surge is correlated with COVID case counts across states. By quantifying the number of excess ILI patients in March relative to previous years and comparing excess ILI to confirmed COVID case counts, we estimate the symptomatic case detection rate of SARS-CoV-2 in the US to be 1/100 to 1/1000. This corresponds to approximately 10 million presumed symptomatic SARS-CoV-2 patients across the US during the week starting on March 15, 2020. Combining excess ILI counts with the date of onset of community transmission in the US, we also show that the early epidemic in the US was unlikely to be doubling slower than every three days. Together these results suggest a conceptual model for the COVID epidemic in the US in which rapid spread across the US are combined with a large population of infected patients with presumably mild-to-moderate clinical symptoms. We emphasize the importance of testing these findings with seroprevalence data, and discuss the broader potential to repurpose outpatient time series for early detection and understanding of emerging infectious diseases.
    52浏览量
    原文链接

  • 《MedRxiv，5月3日，Estimation of SARS-CoV-2 emissions from non-symptomatic cases》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-05-04
    • Estimation of SARS-CoV-2 emissions from non-symptomatic cases View ORCID ProfileMichael Riediker, View ORCID ProfileDai-Hua Tsai doi: https://doi.org/10.1101/2020.04.27.20081398 Abstract Importance: Cases of the coronavirus disease 2019 (COVID-19) with no or mild symptoms were reported to frequently transmit the disease even without direct contact. The severe acute respiratory syndrome virus (SARS-COV-2) was found at very high concentrations in swab and sputum of such cases. Objective: We aimed to estimate virus release from such cases into different aerosol sizes by normal breathing and coughing, and what exposure can result from this in a room shared with such as case. Data Sources and Model: We combined the size-distribution of exhaled breath aerosols for coughing and normal breathing with viral sputum concentrations as approximation for lung lining liquid to obtain an estimate of emitted virus levels. The resulting emission data fed a single-compartment model of airborne concentrations in a room of 50m³, the size of a small office or medical exam room. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    14浏览量
    原文链接